Routine Prophylactic RT After Large-bore Thoracic Interventions Not Appropriate for Mesothelioma

Share this content:
Prophylactic radiation therapy is not recommended for patients with mesothelioma after large-bore thoracic interventions.
Prophylactic radiation therapy is not recommended for patients with mesothelioma after large-bore thoracic interventions.

Prophylactic radiation therapy is not recommended for patients with mesothelioma after large-bore thoracic interventions, according to a study published in the journal The Lancet Oncology.1

Investigators compared prophylactic radiotherapy with deferred radiotherapy, given only when a procedure-tract metastasis developed, in patients with malignant pleural mesothelioma.

For this multicenter, open-label, phase 3 trial, researchers enrolled 203 patients with histocytologically proven mesothelioma, each of whom underwent large-bore pleural interventions in the 35 days before enrollment.

Participants were randomly assigned 1:1 to receive immediate radiotherapy at a dose of 21 Gy in 3 fractions within 42 days of the pleural intervention, or deferred radiotherapy given within 35 days of procedure-tract metastasis diagnosis.

RELATED: Hemithoracic IMPRINT Safe for Locally Advanced Mesothelioma

There was no significant difference in the incidence of procedure-tract metastases between the immediate and deferred radiotherapy arms (9% versus 16%; 0.51 odds ratio; 95% CI, 0.19-1.32; P = .014).

The most common adverse events of immediate radiotherapy were skin toxicity and tiredness or lethargy within 3 months of receiving radiotherapy.

Reference

  1. Clive AO, Taylor H, Dobson L, Wilson P, de Winton E, Panakis N, et al. Prophylactic radiotherapy for the prevention of procedure-tract metastases after surgical and large-bore pleural procedures in malignant pleural mesothelioma (SMART): a multicentre, open-label, phase 3, randomised controlled trial [published online ahead of print June 23, 2016]. Lancet Oncol. doi: 10.1016/S1470-2045(16)30095-X.

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs